-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
The Company Once Again Named Among the “Top 100 Enterprises in Pharmaceutical Internationalization”
Category:
发布时间：2018-11-07
【概要描述】
From June 20 to 22, 2018, the 18th China International Pharmaceutical Ingredients Exhibition was grandly held at the Shanghai New International Expo Center. During the event, the 2018 Top 100 Companies in Pharmaceutical Internationalization were announced, with Shijiazhuang Sihua Pharmaceutical Co., Ltd. making the list and being awarded the title of “Leading Enterprise in Formulation Internationalization.”
From June 20 to 22, 2018, the 18th World Pharmaceutical Ingredients China Exhibition was grandly held at the Shanghai New International Expo Center. During the event, the 2018 Top 100 Companies in Pharmaceutical Internationalization list was unveiled, with Shijiazhuang Sihua Pharmaceutical Co., Ltd. proudly making the cut and being awarded the “Leading Enterprise in Formulation Internationalization” prize. This marks the second consecutive year the company has received this prestigious honor, underscoring the industry’s high level of recognition for Sihua’s business development and once again demonstrating the company’s strong brand influence and corporate value in the pharmaceutical sector.
According to reports, the selection of China’s Top 100 Internationalized Pharmaceutical Companies is organized by the China Chamber of Commerce for Import and Export of Medicines and Health Products, with the aim of recognizing the outstanding contributions made by Chinese pharmaceutical firms to the global pharmaceutical industry chain. To date, this award has earned widespread recognition across the global pharmaceutical sector and enjoys significant social influence.
Through relentless efforts, the company has achieved rapid and steady growth in the international market in recent years. In 2017, it successfully obtained six major international quality design and certification approvals, including those from Ethiopia, the Philippines, Australia’s TGA, and the Netherlands’ IDA, bringing the total number of product registrations to 80 countries and covering 96 distinct product specifications and varieties. Currently, the company has fully aligned itself with international best practices in areas such as R&D capabilities, manufacturing processes and equipment, environmental protection standards, and patent protection.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091